Tag: drugpricing

US Politics

AstraZeneca Bows to Pressure: A Victory for Affordable Medicine or Temporary Concession?

AstraZeneca has agreed to lower prescription drug prices for Medicaid under a deal with the Trump administration, matching the lowest prices offered in other developed nations. This long-overdue victory for American consumers demonstrates how relentless pressure can finally break Big Pharma's stranglehold on affordable healthcare, though we must remain vigilant against potential corporate loopholes.

US Politics

The Pfizer Drug Pricing Deal: Substance or Political Theater?

President Trump and health officials announced a drug pricing deal with Pfizer that claims to save Americans money on prescriptions, but the reality is more complicated with many details still unknown. This feels like another hollow promise that fails to address the systemic greed plaguing our healthcare system while vulnerable Americans continue suffering under crippling drug costs.

US Politics

A Breakthrough in Drug Pricing: Pfizer Agrees to Lower Costs for American Families

President Trump announced that Pfizer agreed to lower drug prices for Medicaid programs and match European pricing for new drugs. This long-overdue victory for American families finally begins to address the pharmaceutical industry's predatory pricing practices that have exploited patients for decades.